Analysed VYOME HOLDINGS INC (HIND:NASDAQ) News Sources
Vyome to Present Compelling Phase 2 Clinical Data on VT-1953 for Treatment of MFW at AACR 2026
06-04-2026
yahoo.com
Vyome Holdings Inc (HIND) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial ...
30-03-2026
yahoo.com
Vyome Reports Transformational 2025 Results: Company Well Positioned for Breakout Phase
26-03-2026
yahoo.com
Livechain Completes Acquisition of Senior, Secured Debt of Humanyze, An MIT Incubated, AI Enabled HR Analytics Company
24-02-2026
yahoo.com
Vyome Announces the Publication of Positive Preclinical Results in Uveitis, Addressing a $3B Potential Market Opportunity
18-02-2026
yahoo.com
Vyome Files for VT-1953 Orphan Drug Status, Furthers Strategic Focus On VT-1953 Program Over the Next 6 Months
11-02-2026
yahoo.com
Vyome Successfully Capitalizes All VT-1953 Funding Requirements For Initial Phase 3 Results
02-02-2026
yahoo.com
Independent Analyst Values Vyome’s VT-1953 at USD 1 Billion Upon Successful Completion of Phase 3 Study
27-01-2026
yahoo.com
What is the current price of VYOME HOLDINGS INC (HIND:NASDAQ)?
The current price of VYOME HOLDINGS INC (HIND:NASDAQ) is $2.26.
VYOME HOLDINGS INC (HIND:NASDAQ) absolute price change since previous trading day?
The absolute price change of VYOME HOLDINGS INC (HIND:NASDAQ) since the previous trading day is $-0.09.
VYOME HOLDINGS INC (HIND:NASDAQ) percentage price change since previous trading day?
The percentage price change of VYOME HOLDINGS INC (HIND:NASDAQ) since the previous trading day is -3.8298%.
What is the most recent average sentiment score for VYOME HOLDINGS INC (HIND:NASDAQ)?
The most recent average sentiment score for VYOME HOLDINGS INC (HIND:NASDAQ) is 62 out of 100.
What is the most recent average sentiment for VYOME HOLDINGS INC (HIND:NASDAQ)?
The most recent sentiment for VYOME HOLDINGS INC (HIND:NASDAQ) is .
SEC-8K** Filing Available For VYOME HOLDINGS INC (HIND:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.